BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35682830)

  • 1. Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine.
    Fila M; Sobczuk A; Pawlowska E; Blasiak J
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Connections of the TRPA1 Ion Channel in Pain Transmission and Neurogenic Inflammation - a Therapeutic Perspective in Migraine?
    Fila M; Pawlowska E; Szczepanska J; Blasiak J
    Mol Neurobiol; 2023 Oct; 60(10):5578-5591. PubMed ID: 37326902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide (CGRP): a new target for migraine.
    Russo AF
    Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
    Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
    Elife; 2021 Apr; 10():. PubMed ID: 33856345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGRP receptor antagonists: toward a novel migraine therapy.
    Salvatore CA; Kane SA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1671-80. PubMed ID: 21466447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
    Durham PL; Vause CV
    CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.
    Edvinsson L
    Expert Opin Ther Targets; 2007 Sep; 11(9):1179-88. PubMed ID: 17845144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine.
    Greco R; Demartini C; Francavilla M; Zanaboni AM; Tassorelli C
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
    Chen ST; Wu JW
    Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel migraine treatment with CGRP-related monoclonal antibodies].
    Shibata M
    Rinsho Shinkeigaku; 2020 Oct; 60(10):668-676. PubMed ID: 32893246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis.
    Tringali G; Navarra P
    Peptides; 2019 Jun; 116():16-21. PubMed ID: 31018157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
    Edvinsson L; Warfvinge K
    Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study.
    Rubino E; Boschi S; Giorgio E; Pozzi E; Marcinnò A; Gallo E; Roveta F; Grassini A; Brusco A; Rainero I
    Neurobiol Pain; 2022; 11():100089. PubMed ID: 35445161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of calcitonin gene-related polypeptide-alpha (CALCA) gene polymorphism with migraine.
    Menon S; Buteri J; Roy B; Murrell M; Quinlan S; Macmillan JC; Lea RA; Haupt LM; Griffiths LR
    Brain Res; 2011 Mar; 1378():119-24. PubMed ID: 21195698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
    Durham PL
    Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.